SynAct Pharma AB (SYNACT) — Working Capital to Net Assets Ratio
SynAct Pharma AB (SYNACT) has a Working Capital to Net Assets ratio of 29.3% as of December 2025. Working capital of Skr49.82 Million (current assets of Skr71.35 Million minus current liabilities of Skr21.52 Million) is measured against net assets of Skr170.29 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See SYNACT net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
SynAct Pharma AB Working Capital to Net Assets (2014–2025)
This chart shows how SynAct Pharma AB's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the ratio stands at 29.3%, reflecting working capital of Skr49.82 Million against net assets of Skr170.29 Million SEK. Check tangible equity quality of SynAct Pharma AB to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for SynAct Pharma AB (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for SynAct Pharma AB from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see SYNACT stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 29.3% | Skr49.82 Million | Skr170.29 Million | Skr71.35 Million | Skr21.52 Million | ▼ -1.3 pp |
| 2024 | 30.6% | Skr65.54 Million | Skr214.17 Million | Skr94.00 Million | Skr28.46 Million | ▲ +2.2 pp |
| 2023 | 28.4% | Skr50.12 Million | Skr176.19 Million | Skr75.06 Million | Skr24.94 Million | ▼ -70.5 pp |
| 2022 | 99.0% | Skr125.22 Million | Skr126.52 Million | Skr140.23 Million | Skr15.01 Million | ▲ +5.4 pp |
| 2021 | 93.6% | Skr19.53 Million | Skr20.87 Million | Skr34.92 Million | Skr15.39 Million | ▼ -4.8 pp |
| 2020 | 98.3% | Skr15.60 Million | Skr15.87 Million | Skr21.33 Million | Skr5.72 Million | ▲ +112.1 pp |
| 2019 | -13.8% | Skr-1.86 Million | Skr13.50 Million | Skr8.45 Million | Skr10.31 Million | ▼ -105.1 pp |
| 2018 | 91.3% | Skr9.42 Million | Skr10.31 Million | Skr13.14 Million | Skr3.72 Million | ▲ +0.2 pp |
| 2017 | 91.1% | Skr11.76 Million | Skr12.91 Million | Skr14.08 Million | Skr2.31 Million | ▼ -4.9 pp |
| 2016 | 96.0% | Skr25.99 Million | Skr27.08 Million | Skr29.48 Million | Skr3.49 Million | ▲ +87.9 pp |
| 2015 | 8.1% | Skr26.00K | Skr320.00K | Skr83.00K | Skr57.00K | ▼ -31.3 pp |
| 2014 | 39.4% | Skr253.00K | Skr642.00K | Skr334.00K | Skr81.00K | — |